FDA Approves Aducanumab — A Controversial Drug For Alzheimer's

FDA Approves Aducanumab — A Controversial Dru...

Up next

How this year's record El Niño could hit your wallet

Peru’s anchovy industry, the largest single-species fishery in the world, is being rocked by the ongoing El Niño . It’s not the first time the fishery has been impacted by the natural weather phenomenon — El Niño gets its name from Peruvian fishermen. And it’s a stark reminder of ...  Show more

An ‘Ozempic baby boom’? The GLP-1 pregnancy plot twist

The explosion of GLP-1 drugs has created a gray zone for pregnancy. That recently prompted the American College of Obstetricians and Gynecologists to issue its first ever guidance on the topic. In a twist, the drugs may boost fertility for some, leading to more pregnancies – a ph ...  Show more

Recommended Episodes

'Some Hope Is Better Than Having No Hope'
The Daily

When the F.D.A. approved the drug Aduhelm, the first Alzheimer’s treatment to receive the agency’s endorsement in almost two decades, it gave hope to many.

But the decision was contentious; some experts say there’s not enough evidence that the treatment can address cogni ...

  Show more

Controversial new Alzheimer's drug in the spotlight
Business Daily

After decades without progress, this June a new treatment was approved by the US Food and Drugs Administration - Biogen's Aduhelm. Ivana Davidovic looks into why this process has been so controversial that is now under investigation by a federal watchdog.Aaron Kesselheim, a Harva ...  Show more

Alzheimer’s drug has experts divided; rising ICE use in Australia; the disappointing results of a study aimed at improving ovarian cancer survival rates
Health Report - Full program podcast

This week, the first of a new series on substance use and what you need to know about ICE - crystal meth. Does early diagnosis of ovarian cancer through screening make a difference to survival rates? And the search for an Alzheimer's disease treatment is as controversial as ever. ...  Show more